Clinical Trial

Validation of Drug Assays in Various Biological Matrices

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to ensure that assays that measure drug concentrations are accurate and precise in different matrices when quantified using high performance liquid chromatography -tandem mass spectrometry (HPLC-MS/MS). The study involves collecting samples of various bodily fluids to quantify antimicrobials, antivirals, oral contraceptives and erectile dysfunction agents. Samples will also be obtained from individuals not receiving these medications for quality control purposes.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2014-11-04; most recent amendment 2026-05-06.
Trial Details
NCT Number NCT02283112
Lead Sponsor University of Liverpool
Conditions Infection
Enrollment 100 participants
Start Date 2014-10
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-11